| Title |
Bisphosphonatassoziierte Osteonekrose des Kiefers
|
|---|---|
| Published in |
Oral and Maxillofacial Surgery, February 2006
|
| DOI | 10.1007/s10006-005-0670-0 |
| Pubmed ID | |
| Authors |
M. H. Abu-Id, Y. Açil, J. Gottschalk, T. Kreusch |
| Abstract |
Bisphosphonates (BP) are widely used in patients with osteoporosis or malignant tumors with bony metastases such as breast cancer and plasmocytoma because of their potency to affect osteoclasts and bone resorption. Osteonecrosis of the jaw (ONJ) has been described as a potential side effect since 2003. After a review of the literature we present results of a questionnaire, which was sent to departments of oral and maxillofacial surgery (OMFS) in German-speaking countries. |
Mendeley readers
The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 7% |
| Unknown | 13 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 4 | 29% |
| Student > Bachelor | 3 | 21% |
| Student > Postgraduate | 3 | 21% |
| Student > Master | 2 | 14% |
| Student > Ph. D. Student | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 1 | 7% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 71% |
| Agricultural and Biological Sciences | 3 | 21% |
| Unknown | 1 | 7% |